Skip to main content

Personalized Biological Therapies

  • Chapter
  • First Online:
Textbook of Personalized Medicine
  • 2342 Accesses

Abstract

Historically blood transfusion and organ transplantation were the first personalized therapies as they were matched to the individuals. Some cell therapies that use patient’s own cells are considered to be personalized medicines particularly vaccines prepared from the individual patient’s tumor cells. More recently recombinant human proteins might provide individualization of therapy. The number of biotechnology-based therapeutics introduced in medical practice is increasing along with their use in a personalized manner (Jain 2012).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Dhiman N, Ovsyannikova IG, Vierkant RA, et al. Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results. Vaccine. 2008;26:1731–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Jain KK. Personalized cancer vaccines. Expert Opin Biol Ther. 2010;12:1637–47.

    Article  Google Scholar 

  • Jain KK. Role of biological therapies in the development of personalized medicine. Expert Opin Biol Ther. 2012;12:1–5.

    Article  CAS  PubMed  Google Scholar 

  • Jain KK. Cell therapy: technologies, markets and companies. Basel: Jain PharmaBiotech; 2015a.

    Google Scholar 

  • Jain KK. Gene therapy: technologies, markets and companies. Basel: Jain PharmaBiotech; 2015b.

    Google Scholar 

  • Jain KK. RNAi: technologies, markets and companies. Basel: Jain PharmaBiotech; 2015c.

    Google Scholar 

  • Kim C. Disease modeling and cell based therapy with iPSC: future therapeutic option with fast and safe application. Blood Res. 2014;49:7–14.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Mavroudi M, Zarogoulidis P, Porpodis K, et al. Stem cells’ guided gene therapy of cancer: new frontier in personalized and targeted therapy. J Cancer Res Ther (Manch). 2014;2:22–33.

    Article  CAS  Google Scholar 

  • Mook OR, Baas F, de Wissel MB, Fluiter K. Allele-specific cancer cell killing in vitro and in vivo targeting a single-nucleotide polymorphism in POLR2A. Cancer Gene Ther. 2009;16:532–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Jain, K.K. (2015). Personalized Biological Therapies. In: Textbook of Personalized Medicine. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2553-7_9

Download citation

Publish with us

Policies and ethics